Sergio Bautista-Arredondo National Institute of Public Health Mexico

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
HEA PTP: M207 Health Economics1 Measurement & Valuation of Health What is health? Why do we need to measure it? How can it be measured? Why do we need.
Donald T. Simeon Caribbean Health Research Council
Knowing if the RBF mechanism is working Incorporating Rigorous Impact Evaluation into your HRBF program Sebastian Martinez World Bank.
Knowledge Translation Curriculum Module 3: Priority Setting Lesson 2 - Interpretive Priority Setting Processes.
Summary Measures of Population Health: Measuring the impact of disease, injuries and risk factors.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
Valuation issues Jan Sørensen, Health Economist CAST – Centre for Applied Health Services Research and Technology Assessment University of Southern Denmark.
Non-parametric Bayesian value of information analysis Aim: To inform the efficient allocation of research resources Objectives: To use all the available.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
Cost-Benefit / Cost-Effectiveness Analysis in the Context of Impact Evaluations MC Evaluation Workshop and Operations Meeting January 18-23, 2010 Johannesburg,
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
1 Econoqualimetrics Edward Broughton, PhD., MPH Senior Economic Analyst, USAID Health Care Improvement Project, EnCompass,
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Cost and Cost-Effectiveness Analysis.  Public and private resources limited. Decision- makers make choices about resource allocation; it is only a question.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
HSA 171 CAR. 1436/ 7/4  The results of activities of an organization or investment over a given period of time.  Organizational Performance: ◦ A measure.
Introduction to the Sustainability Framework Karl Blanchet, 2009 Adapted from Ricca J., 2009, CSTS.
Adjustment of benefit Size and composition of transfer in Kenya’s CT-OVC program Carlo Azzarri & Ana Paula de la O Food and Agriculture Organization.
MDG Needs Assessment Training Workshop May 9-12, 2005 Health Module.
Primer on Monitoring and Evaluation. The 3 Pillars of Monitoring and Evaluation  Identifying the Performance Indicators  Collecting information using.
Valuing intangible costs of substance abuse in monetary terms Claude Jeanrenaud, Sonia Pellegrini IRER, University of Neuchâtel Neuchâtel October 25 th,
Learning about learning The GEC approach to M&E UKFIET Conference Joseph Holden & Jason Calvert 15 th September 2015 © PEAS.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 6: Cost-effectiveness analysis – Part.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Ministry of Healthcare & Nutrition Broader Approaches to Health Strategic Frame Work for Health Development.
National Institute of Public Health Cuernavaca Mexico Costs and Costing Cost Benefit Analysis Cost Effectiveness Analysis Stefano Bertozzi March, 2008.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 3 Valuing the Environment: Methods.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.
Cost and Benefits. Introduction Is treatment X worth it?
Farid Abolhassani What is economic evaluation 16.
Introduction to Monitoring and Evaluation. Learning Objectives By the end of the session, participants will be able to: Define program components Define.
Summary Measures of Population Health Topics in Public Health April Sung-Il Cho.
HEALTH ECONOMICS BASICS
Global burden of diseases
Module 2 Basic Concepts.
Measuring Results and Impact Evaluation: From Promises into Evidence
Public Financial Management: An Introduction
Prof. Md Sayedur Rahman Pharmacoeconomics: Bangladesh Perspective
Impact and costing of cardiovascular disease treatmentin Kwara State Health Insurance (KSHI) program. University of Ilorin Teaching Hospital (UITH) Amsterdam.
Fundamentals of Monitoring and Evaluation
Siriporn Poripussarakul, Mahidol University, Thailand
DY6 Core Component & Sustainability Reporting
Economic Evaluation of Health Interventions Basic Concepts
Descriptive Analysis of Performance-Based Financing Education Project in Burundi Victoria Ryan World Bank Group May 16, 2017.
JANPA FINAL CONFERENCE
NAPLEX preparation: Biostatistics
College of Public Health and Human Sciences
Measuring Health Status
ESTIMATING THE LIFETIME COST OF CHILDHOOD OBESITY: MAIN CONCLUSIONS
Performance Management May 2011
INDICATORS OF HEALTH.
IV-E Prevention Family First Implementation & Policy Work Group
Module 4 Part 2 Selecting Measures
INDICATORS OF HEALTH.
EPIDEMIOLOGY AS A TOOL TO EVALUATE QUALITY OF CARE
Different measures of health status of Australians
Integrating Gender M&E Capacity Strengthening Workshop, Addis Ababa
Measuring outcomes Emma Frew October 2012.
Calculating Costs of Care at UCSF
Data for PRS Monitoring: Institutional and Technical Challenges
Impact of quality on day-to-day efforts of PHC
Presentation transcript:

Sergio Bautista-Arredondo National Institute of Public Health Mexico Cost Benefit / Cost Effectiveness Analysis Impact Evaluation Support Network Health Results-Based Financing Sergio Bautista-Arredondo National Institute of Public Health Mexico

CBA and CEA CBA – What is the net social benefit resulting from a program / intervention? Measured in monetary terms CEA – What is cost per unit of outcome “purchased” with an intervention? Cost per birth attended by skilled health personnel Cost per vaccinated child

Why in the context of impact evaluation? Impact Evaluation tells whether an intervention works or not What is the effect of the intervention? CBA / CEA tells how much the effect costs Efficiency implications Equity implications

How to do it? Measure the consequences of the intervention Effects Costs CBA : determine the net benefits C - E Value effects in monetary terms CEA : determine the cost per unit of outcome: C / E

Objective Evaluate the efficiency and sustainability of different approaches of HRBF Assess the incremental costs of these interventions, as well as their impact To develop costing protocols for the country impact evaluations in the HRBF pilot projects Appropriate to assess cost-effectiveness and cost-benefit of RBF interventions

Costing HRBF Measuring costs of the interventions Relevant categories Measuring issues Data sources Aggregating benefits / effects of the interventions CBA Willingness to pay Other alternatives DALYs QUALYs

Costing HRBP Measuring costs of the interventions Relevant categories Measuring issues Data sources Aggregating benefits / effects of the interventions CBA Willingness to pay Other alternatives DALYs QUALYs

Relevant Categories HRBF Administration Management of the programs Implementation Monetary incentives Training / contracting staff Increasing equipment Monitoring system Developing the system Data entry and management Audits and verification mechanisms Staff

General vs Specific Important differences among countries: Health System M&E existing systems HRBF interventions Develop a general protocol that will have to be adapted in each country

Measuring Issues Perspective Time frame Measure initial / fixed costs Implementing agency / agencies Time frame Measure the marginal/incremental costs of implementation between baseline and follow up Able to assess the marginal cost of the impact observed Measure initial / fixed costs Measure ongoing / variable costs Take scale into consideration

Data Sources Administrative data Survey data Budget information from the three components Survey data Facility level surveys to assess Allocation of resources to specific components of the program and to specific outcomes Validate administrative data

Allocation of costs to outcomes Labor L C I Clinic Capital Inputs Vaccined Children Cancer tests performed Controled diabetes patients

Costing HRBP Measuring costs of the interventions Relevant categories Measuring issues Data sources Aggregating benefits / effects of the interventions CBA Willingness to pay Other alternatives DALYs QUALYs

Cost Benefit Analysis In order to aggregate different health outcomes: Conduct cost-benefit analysis – we need to value in monetary terms the outcomes of the interventions One approach: contingent valuation Measuring wtp for contingent states or interventions The objective is to determine the maximum monetary amount that individuals are willing to pay for the state or intervention Estimate weights to add up different outcomes

Willingness to pay Describing the hypothetical intervention that achieves the outcome of interest and eliciting the wtp from respondents: Forces respondents to consider trade-offs between attributes Makes the frame of reference explicit to respondents via the inclusion of an array of attributes and alternatives Enables implicit prices to be estimated for attributes of interventions Enables welfare impacts to be estimated for multiple scenarios

DALYs Disability adjusted life years (DALY) DALYs for a disease are the sum of the years of life lost due to premature mortality (YLL) in the population and the years lost due to disability (YLD) for incident cases of the health condition DALY = YLL + YLD

QUALYs A quality-adjusted life-year (QALY) takes into account both quantity and the quality of life generated by healthcare interventions It is the arithmetic product of life expectancy and a measure of the quality of the remaining life-years Perfect health = 1 and Death = 0

Sources of data Household Survey Estimate QALYs or DALYs Include a wtp module in the household questionnaire Estimate QALYs or DALYs These weights have been estimated for most common health outcomes For different contexts